Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Abstract Background Utilization of electronic patient-reported outcome (ePRO) tools to monitor symptoms in patients undergoing cancer treatment has shown clinical benefits. Tennessee Oncology (TO) implemented an ePRO platform in 2019, allowing patients to report their health status online. We conduc...
Saved in:
Main Authors: | Natalie R Dickson (Author), Karen D Beauchamp (Author), Toni S Perry (Author), Ashley Roush (Author), Deborah Goldschmidt (Author), Marie Louise Edwards (Author), L Johnetta Blakely (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategic Consensus on the Value of Immuno-Oncology in Portugal
by: . .
Published: (2016) -
Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020) -
Novel strategies for immuno-oncology breakthroughs with cell therapy
by: Hongtao Liu, et al.
Published: (2021) -
Immuno-Oncology Medicines: Policy Implications and Economic Considerations
by: Georges Adunlin, et al.
Published: (2019) -
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
by: Jeong Mo Bae, et al.
Published: (2020)